Philadelphia — With the Centers for Disease Control and Prevention estimating that more than 130 people in the United States die each day from overdosing on opioids, the misuse of and addiction to opioids has become a national health crisis. In conjunction with the U.S. Food and Drug Administration (FDA), the National Academies of Sciences,...
Penn Dental Medicine faculty/staff members were honored for excellence in teaching by the School’s graduating class of DMD students with the 2018 teaching awards
The Philly Inquirer talked to Dr. Hersh in its coverage of the recent policy released by the ADA on opioids. He noted that opioids should not be the first line of pain relief.
Dr. Shanti, who joined the faculty last year, is working to better understand oral cancers and to design new structures to replace the tissues his patients lose to surgery.
Penn Dental Medicine faculty/staff members were honored for excellence in teaching by the School’s graduating class with the 2017 teaching awards.
Dr. Mupparapu, Professor of Oral Medicine, has been on the faculty since 2012. Penn presents eight Lindback awards each year for teaching excellence.
Taking a look at drugs to manage dental pain, Consumer Reports talks with Dr. Elliot Hersh on the effectiveness of over-the-counter options vs. prescription opioids.
Dr. Elliot Hersh, Professor, Dept. of Oral Surgery/Pharmacology, was interviewed by WHYY's The Pulse for a story on opioids and their potential for abuse.
The award recognizes exemplary contributions to expanding interdisciplinary collaboration at Penn. Dr. Hersh and colleagues from medicine and nursing lead an interdisciplinary course on pain science and practice.
The spray, a drug called Kovanaze, was deemed safe and effective in a recent Phase 3 clinical trial led by Dr. Elliot Hersh, Professor, Dept. of Oral Surgery/Pharmacology.
